Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nuvation Bio, Inc.

7.15
+2.3548.96%
Post-market: 7.200.0500+0.70%19:59 EST
Volume:59.11M
Turnover:401.22M
Market Cap:2.45B
PE:-11.17
High:7.35
Open:4.99
Low:4.94
Close:4.80
52wk High:7.35
52wk Low:1.54
Shares:342.83M
Float Shares:231.05M
Volume Ratio:8.07
T/O Rate:25.58%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6400
EPS(LYR):-2.1131
ROE:-52.49%
ROA:-24.82%
PB:7.52
PE(LYR):-3.38

Loading ...

Nuvation Bio Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Nov 04

Nuvation Bio Highlights Breakthrough Oncology Advances and IBTROZI Launch in Corporate Presentation

Reuters
·
Nov 04

Nuvation Bio beats Q3 revenue expectations, driven by IBTROZI sales

Reuters
·
Nov 04

Nuvation Bio Q3 EPS USD -0.16

Reuters
·
Nov 04

Nuvation Bio reports $7.7 million net product revenue for Q3 2025

Reuters
·
Nov 04

Nuvation Bio Q3 Income From Pperations USD -56.434 Million

THOMSON REUTERS
·
Nov 04

Corrected-Nuvation Bio Q3 Revenue USD 13.1 Million VS. Ibes Estimate USD 6.8 Million (Corrects Amount)

THOMSON REUTERS
·
Nov 04

Nuvation Bio Chief Scientific Officer Gary Hattersley Reports Disposal of Common Shares

Reuters
·
Oct 30

Assessing Nuvation Bio (NUVB) Valuation Following Phase 3 Safusidenib Trial Milestone

Simply Wall St.
·
Oct 25

Nuvation Bio enrolls first patient in G203 study

TIPRANKS
·
Oct 23

BRIEF-Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma

Reuters
·
Oct 23

Press Release: Nuvation Bio to Report Third Quarter 2025 Financial Results and Provide Business Update on November 3, 2025

Dow Jones
·
Oct 21

Nyse Order Imbalance 431767.0 Shares on Buy Side

THOMSON REUTERS
·
Oct 21

Nuvation Bio (NUVB): Assessing Valuation After Key Phase 3 TRUST-IV Trial Milestone

Simply Wall St.
·
Oct 15

Nuvation Bio Price Target Maintained With a $6.00/Share by Wedbush

Dow Jones
·
Oct 13

Nuvation Bio (NUVB) Receives a Buy from RBC Capital

TIPRANKS
·
Oct 10

NYSE Content Advisory: Pre-Market Update + The AW Playmaker Awards Take the Stage at 11 Wall Street

prnewswire
·
Oct 08

Nuvation Bio (NUVB): Valuation in Focus as Phase 3 Lung Cancer Trial Launches

Simply Wall St.
·
Oct 08

Rapid Micro Biosystems And 2 Promising Penny Stocks To Watch

Simply Wall St.
·
Oct 07

Nuvation Bio Shares Rise After First Patient Enrolled in Phase 3 Lung Cancer Drug Trial

MT Newswires Live
·
Sep 30